Dihydromyricetin, better known as DHM, is the compound sold in "hangover relief" capsules and drink mixes. A new study suggests it may do something else in a very small animal: it lengthened lifespan and protected aging neurons. Before anyone changes their supplement stack, the caveat belongs up front. This was a roundworm study. There are no human longevity data.
What the researchers actually did
A team from Chosun University and Chonnam National University in South Korea tested DHM in Caenorhabditis elegans, a transparent roundworm widely used in aging research. The paper appeared in Antioxidants and examined lifespan, neuron integrity, oxidative stress resistance, mitochondrial status, and fat handling.
DHM is a dietary flavanonol, a plant compound type with a reputation for antioxidant and neuroprotective effects. It has also been linked to mitochondrial health. What had not been worked out was how it interacts with mitochondrial quality control during aging, which is the gap this study set out to fill.
The headline numbers: up to 15% longer mean lifespan
Worms treated with DHM at 50 to 200 micromolar (μM) had a mean lifespan 9.1% to 15.0% longer than untreated worms. Note that this refers to mean lifespan, not a claim that the oldest worms lived dramatically longer.
The treated worms also showed signs of better healthspan:
- Less neuron degeneration. Touch-receptor neurons known as ALM and PLM showed less age-related damage.
- Better movement. Locomotor performance held up into later adulthood.
- Preserved touch response. The anterior touch response was maintained as the worms aged.
- Better survival under oxidative stress. DHM-treated worms did better after a challenge with juglone, a compound that induces oxidative stress.
In test-tube assays (DPPH and ABTS), DHM also showed strong radical-scavenging activity, which fits its reputation as an antioxidant.
The mitochondria angle
This is where the study gets interesting. DHM modestly lowered TMRE fluorescence, a readout related to mitochondrial membrane potential. In a separate cohort with a different exposure schedule, mitochondrial DNA copy number did not differ significantly from controls.
The researchers also saw more GFP-negative/mCherry-positive mitochondrial puncta in ALM neurons. That pattern is consistent with a shifted mitochondrial energetic state and more mitochondria being trafficked to acidic degradative compartments, which is the kind of cleanup associated with mitochondrial quality control. The authors describe it as consistent with that interpretation, not as proof.
Not a simple "antioxidant" story
One of the more instructive findings is what didn't happen. Two canonical antioxidant-response reporters, SOD-3 and GST-4, were not significantly induced. If DHM were simply boosting the worms' own antioxidant defenses, you would expect them to light up. They did not.
The lifespan benefit also persisted in daf-16(mu86) mutants, so it does not appear to depend on DAF-16, the worm's well-known FOXO longevity factor. An exploratory statistical model found no evidence of a genotype-by-dose interaction.
The neuroprotective effect still appeared in ucp-4(ok195) mutants, but was not statistically detected in pink-1(tm1779); pdr-1(gk448) double mutants. These two genes are the worm counterparts of PINK1 and Parkin, central to clearing damaged mitochondria. That hints at a role for mitophagy-related pathways. However, the authors did not run a formal cross-genotype interaction test, so they treat this as hypothesis-generating, not definitive.
Less fat, too
DHM lowered intestinal lipid stores and suppressed expression of fat-5, fat-6, and fat-7, genes involved in fatty acid desaturation. It also modestly upregulated atfs-1, a regulator of the mitochondrial stress response. The authors conclude that DHM is associated with healthspan-related phenotypes alongside coordinated redox, mitochondrial quality-control, and metabolic changes. The wording is "associated with," and it is deliberate.
Why this doesn't translate to your capsule
A few reasons to keep your enthusiasm in check:
- Worms are not people. C. elegans is a valuable model, but many lifespan extenders in worms fail to do anything comparable in mammals.
- Micromolar is not milligrams. The 50 to 200 μM concentrations apply to the worms' environment. They can't be converted into a capsule dose for a human. Absorption, metabolism, and tissue levels differ enormously, and DHM is generally described as having limited bioavailability. The paper does not offer a human dose.
- No human longevity data. The study says nothing about whether DHM extends human life or protects human neurons.
- Mean lifespan, not maximum. The gains were reported for mean lifespan.
Practical takeaways
What people buy. DHM is commonly sold as capsules or powder, often under the names dihydromyricetin or ampelopsin, and is frequently derived from Hovenia dulcis extract. It is mostly marketed for hangovers and liver support, not longevity. This study provides no basis for a longevity dose.
Who might find this interesting. People who follow aging biology and mitochondrial quality control will find it a useful preclinical lead, particularly the idea that DHM works through something other than classic antioxidant induction.
Who should be cautious or skip it. Anyone expecting proven anti-aging benefits should hold off. People who are pregnant or nursing, have liver conditions, or take prescription medications should talk with a clinician before using any concentrated plant extract. Nothing in this paper establishes safety or efficacy in humans.
The bottom line
This study shows that DHM extended mean lifespan by up to 15% in roundworms, preserved neurons and movement, lowered fat stores, and altered mitochondrial markers. It is a genuinely interesting preclinical result, and the mutant data suggest mechanisms worth testing. But it remains a worm study with hypothesis-level mechanistic claims. The next real tests would be in mammals, and eventually in humans.